Gamida Cell Ltd (GMDAQ)

[midastouch017]

Gamida Cell Announces Closing of $75 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Mon, December 21, 2020, 11:30 PM GMT+2

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced that its previously announced public offering closed on December 21, 2020. The total number of ordinary shares sold by the Company in the offering was 9,343,750, inclusive of the full exercise of the underwriters’ option to purchase up to an additional 1,218,750 shares, at the public offering price of $8.00 per share, less underwriting discounts and commissions. After giving effect to the option closing, the shares sold by the Company resulted in aggregate gross proceeds to the Company of $74.75 million before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

Piper Sandler & Co., Evercore Group L.L.C. and JMP Securities LLC acted as joint book-running managers for this offering.

https://finance.yahoo.com/news/gamida-cell-announces-closing-75-213000780.html

A very succesful offering judging by the results!